Asked by: Antonia Bance (Labour - Tipton and Wednesbury)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, what assessment she has made of the potential impact of charging a 5% surcharge when paying vehicle tax by direct debit on lower income motorists; and whether she has plans to remove this surcharge.
Answered by Dan Tomlinson - Exchequer Secretary (HM Treasury)
When Vehicle Excise Duty (VED) is paid monthly or six-monthly, rather than annually, the cost to the exchequer is higher because of lost interest. To reflect this impact on the public finances, the previous government introduced in 2014 an extra charge for monthly and six-monthly VED payments to make up for the lost interest
The Government annually reviews the rates and thresholds of taxes and reliefs to ensure that they are appropriate and reflect the current state of the economy. The Chancellor makes decisions on tax policy at fiscal events in the context of the public finances.
Asked by: Antonia Bance (Labour - Tipton and Wednesbury)
Question to the Home Office:
To ask the Secretary of State for the Home Department, what assessment she has made of the potential merits of updating the 10-Year Drugs Plan to reflect (a) the increase in ketamine use and (b) other changes in the drugs landscape.
Answered by Sarah Jones - Minister of State (Home Office)
Ketamine is a dangerous substance, which can cause irreversible bladder damage and in some cases death. Ministers are very concerned about the harms ketamine causes and on 16 October 2025 the Department for Health and Social Care launched a campaign to alert young people to the dangers of that drug (as well as counterfeit medicines containing synthetic opioids, and THC vapes).
Ketamine was moved from Class C to Class B within Schedule 2 to the Misuse of Drugs Act 1971 (MDA) in 2014, following a review of its harms by the Advisory Council on the Misuse of Drugs (ACMD). The ACMD noted that "although there is limited evidence of ketamine misuse causing social harm, evidence of physical harm (mainly chronic bladder toxicity but also an increase in acute toxicity) has increased".
We have not carried out an assessment of the effects of that reclassification. The drivers of the availability, market price and prevalence of drugs are complex. The control of drugs under the MDA is an important means of reducing their availability and gives law enforcement the powers to target criminals involved in supplying harmful substances. In 2024 there were 2,014 prosecutions and 1,507 convictions in England and Wales for offences relating to the possession and trafficking of ketamine.
In January 2025 the Government asked the ACMD to provide an updated harms assessment of ketamine. The ACMD carried out a public call for evidence in August and we expect to receive its report by the end of 2025. We will carefully consider its recommendations.